Recall of Cannabis for Medical Purposes – Aphria

Starting date:

January 25, 2018

Posting date:

January 30, 2018

Type of communication:

Drug Recall

Subcategory:

Drugs

Hazard classification:

Type III

Source of recall:

Health Canada

Issue:

Labelling and Packaging

Audience:

General Public

Identification number:

RA-65848

• 
  Reason
• 
  Affected products
• 
  Media enquiries

Introduction

On January 25, 2018, Aphria, a licensed producer of cannabis for medical purposes located in Ontario, began a voluntary Type III recall of two lots of dried marijuana that were produced between January 19 and January 22, 2018. The affected lot number(s) are found below.

Reason

On January 25, 2018, Aphria initiated a voluntary Type III recall for two lots of dried marijuana sold in 10 g bottles, due to a labelling error. The labels omitted to indicate the percent sign (%) next to the numerical values for cannabinoid content.

A Type III recall refers to a situation in which the use of, or exposure to, a product is not likely to cause any adverse health consequences.

To date, Health Canada has not received any adverse reaction reports for products sold by Aphria. However, Health Canada recommends that any individual affected by the recall immediately stop using the recalled product and contact Aphria at the following number 1-844-427-4742.

Affected products

Media enquiries

Health Canada

(613) 957-2983